Bextra, also known as Valdecoxib, was
approved by the FDA in 2001 for the treatment of pain, tenderness, and
swelling caused by osteoarthritis and adult rheumatoid arthritis. Bextra
is supposed to decrease your level of suffering, but for some people it
brought about a whole new range of problems.
Belonging to a class of nonsteroidal anti-inflammatory
medications (NSAIDs) called COX-2 inhibitors, Bextra is a compound that
blocks the COX-2 enzyme, the prime cause of pain and inflammation in
arthritis. In some people, especially those with allergies to
sulfonamides, Bextra has shown far more dramatic side effects than first
believed to be capable of. Sadly, some of those side effects could prove
Personal Injury Attorney Disclaimer: This website provides general information about Pennsylvania Bextra lawsuits, Philadelphia Bextra lawsuits, and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.